Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

PM Society Award Winners 2006

Craft Award:Detailing Aid. Winner:Seven Stones for Avonex. Sponsor: Ashfield Healthcare. Craft Award:GP Direct Mail Campaign. ... Sponsor:Wiley Pharmafile. Craft Award:Hospital Campaign. Winner:Seven Stones for Avonex. Sponsor: TNS Healthcare.

New accounts: January

Biogen. Avonex. Multiple sclerosis. Brader Perryman. Cambridge Laboratories. Gelclair. Oncology/ENT. RFA Advertising.

Double or quits!

Avonex (Biogen Idec) and Rebif (Serono) are recombinant human inter-feron B-1a products; administration is via subcutaneous (SC) injection once- and thrice-weekly, respectively. ... However, Avonex can also be used for a single neurological event

New accounts: February

Biogen. Avonex. Multiple sclerosis. Brader Perryman. Eden Biodesign. N/A. Corporate. Affiniti (UK).

Turbulent times

The companies revealed that one patient had died after taking Tysabri for two years in combination with Avonex while a second was suspected of developing a central nervous system disease.

[ Previous 5 results ] 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...